US 12145974
Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulin
granted A61KA61K38/00A61P
Quick answer
US patent 12145974 (Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulin) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00, A61P, A61P1/16, A61P3/04